These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 18407779)

  • 1. Topology optimization of a novel stent platform with drug reservoirs.
    Wu W; Yang DZ; Huang YY; Qi M; Wang WQ
    Med Eng Phys; 2008 Nov; 30(9):1177-85. PubMed ID: 18407779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-eluting stent strut distribution: a comparison between Cypher and Taxus by optical coherence tomography.
    Suzuki Y; Ikeno F; Yeung AC
    J Invasive Cardiol; 2006 Mar; 18(3):111-4. PubMed ID: 16598109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling of size dependent failure in cardiovascular stent struts under tension and bending.
    Harewood FJ; McHugh PE
    Ann Biomed Eng; 2007 Sep; 35(9):1539-53. PubMed ID: 17503185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of stent design parameters on normal artery wall mechanics.
    Bedoya J; Meyer CA; Timmins LH; Moreno MR; Moore JE
    J Biomech Eng; 2006 Oct; 128(5):757-65. PubMed ID: 16995763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Finite element analysis and stent design: Reduction of dogboning.
    De Beule M; Van Impe R; Verhegghe B; Segers P; Verdonck P
    Technol Health Care; 2006; 14(4-5):233-41. PubMed ID: 17065746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strut position, blood flow, and drug deposition: implications for single and overlapping drug-eluting stents.
    Balakrishnan B; Tzafriri AR; Seifert P; Groothuis A; Rogers C; Edelman ER
    Circulation; 2005 Jun; 111(22):2958-65. PubMed ID: 15927969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Realistic finite element-based stent design: the impact of balloon folding.
    De Beule M; Mortier P; Carlier SG; Verhegghe B; Van Impe R; Verdonck P
    J Biomech; 2008; 41(2):383-9. PubMed ID: 17920068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug release kinetics from stent device-based delivery systems.
    Tesfamariam B
    J Cardiovasc Pharmacol; 2008 Feb; 51(2):118-25. PubMed ID: 18287878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The platinum chromium element stent platform: from alloy, to design, to clinical practice.
    Menown IB; Noad R; Garcia EJ; Meredith I
    Adv Ther; 2010 Mar; 27(3):129-41. PubMed ID: 20437213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of through-hole drug reservoirs on key clinical attributes for drug-eluting depot stent.
    Hsiao HM; Chiu YH; Wu TY; Shen JK; Lee TY
    Med Eng Phys; 2013 Jul; 35(7):884-97. PubMed ID: 22995147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virtual optimization of self-expandable braided wire stents.
    De Beule M; Van Cauter S; Mortier P; Van Loo D; Van Impe R; Verdonck P; Verhegghe B
    Med Eng Phys; 2009 May; 31(4):448-53. PubMed ID: 19117791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Finite element shape optimization for biodegradable magnesium alloy stents.
    Wu W; Petrini L; Gastaldi D; Villa T; Vedani M; Lesma E; Previtali B; Migliavacca F
    Ann Biomed Eng; 2010 Sep; 38(9):2829-40. PubMed ID: 20446037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of current devices and a look at new technology: drug-eluting stents.
    Nakazawa G; Finn AV; Kolodgie FD; Virmani R
    Expert Rev Med Devices; 2009 Jan; 6(1):33-42. PubMed ID: 19105778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-objective optimization of nitinol stent design.
    Alaimo G; Auricchio F; Conti M; Zingales M
    Med Eng Phys; 2017 Sep; 47():13-24. PubMed ID: 28705512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genous endothelial progenitor cell-capturing stent system: a novel stent technology.
    Klomp M; Beijk MA; de Winter RJ
    Expert Rev Med Devices; 2009 Jul; 6(4):365-75. PubMed ID: 19572791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sculptured drug-eluting stent for the on-site delivery of tacrolimus.
    Minghetti P; Cilurzo F; Selmin F; Casiraghi A; Grignani A; Montanari L
    Eur J Pharm Biopharm; 2009 Nov; 73(3):331-6. PubMed ID: 19686848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of clinical long-term benefit with the use of a drug eluting stent compared to use of a bare metal stent in saphenous vein grafts.
    Gioia G; Benassi A; Mohendra R; Chowdhury K; Masood I; Matthai W
    Catheter Cardiovasc Interv; 2008 Jul; 72(1):13-20. PubMed ID: 18561143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioabsorbable and biocompatible stents. Is a new revolution coming?
    Rogacka R; Chieffo A; Latib A; Colombo A
    Minerva Cardioangiol; 2008 Oct; 56(5):483-91. PubMed ID: 18813184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug-eluting stents for diabetic patients. A critical appraisal of the currently available data from randomized trials].
    Silber S; Herdeg C
    Herz; 2008 Apr; 33(3):196-205. PubMed ID: 18568314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time dependent vascular and myocardial responses of a second generation, small vessel, paclitaxel-eluting stent platform.
    Thompson CA; Huibregtse B; Poff B; Wilson GJ
    Catheter Cardiovasc Interv; 2009 Apr; 73(5):597-604. PubMed ID: 19180652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.